Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis
- PMID: 26201812
- DOI: 10.1007/s12072-012-9408-x
Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis
Abstract
Background and aims: Accumulating evidence suggests that deterioration of the gut flora contributes to the pathogenesis of alcoholic liver cirrhosis (ALC). However, the ALC flora profile and its response to probiotic treatment have not been fully examined. This double-blind placebo-controlled study aimed to evaluate whether the probiotic beverage Yakult 400 (Y400), which contains Lactobacillus casei strain Shirota, improves liver function in ALC patients, and to analyze the precise gut flora profile by real-time quantitative PCR (qPCR).
Methods: A total of 37 hospitalized ALC patients were randomly allocated to Y400 (n = 18) and placebo (n = 19) groups. Y400 or placebo was served twice a day during the first half of the four-week study. Serum concentrations of rapid-turnover proteins (i.e., transthyretin and transferrin), hypersensitive C-reactive protein, and interleukin-6 were measured weekly. qPCR analysis of fecal bacteria was performed biweekly; stocked fecal samples from 46 healthy subjects were used as references.
Results: Serum transthyretin levels significantly increased in the Y400 group in week 3; similar-although statistically insignificant-increases were seen for transferrin and albumin. Levels of hypersensitive C-reactive protein, but not interleukin-6, significantly decreased in week 4. Before treatment, populations of obligate anerobic bacteria were significantly smaller and those of Enterobacteriaceae were larger in patients than in healthy subjects examined in a previous study. Y400 corrected this imbalance.
Conclusions: This is the first report describing the unique gut flora of ALC patients. Y400 treatment normalized the gut flora and improved liver function. These promising findings warrant further investigation in larger, multicenter studies.
Keywords: Lactobacillus; Randomized placebo-controlled study; Real-time quantitative PCR (qPCR); Transthyretin.
Similar articles
-
Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.J Am Coll Nutr. 2015;34(6):459-69. doi: 10.1080/07315724.2014.983249. Epub 2015 Apr 24. J Am Coll Nutr. 2015. PMID: 25909149 Clinical Trial.
-
The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1. J Clin Gastroenterol. 2012. PMID: 22157240 Clinical Trial.
-
Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study.Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1300-6. doi: 10.1097/MEG.0000000000000458. Eur J Gastroenterol Hepatol. 2015. PMID: 26302024 Clinical Trial.
-
Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate.J Gastroenterol Hepatol. 2008 Dec;23(12):1834-9. doi: 10.1111/j.1440-1746.2008.05723.x. J Gastroenterol Hepatol. 2008. PMID: 19120873
-
Gut microbiota and host metabolism in liver cirrhosis.World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597. World J Gastroenterol. 2015. PMID: 26556989 Free PMC article. Review.
Cited by
-
Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: A systematic review and meta-analysis.Clin Exp Hepatol. 2023 Jun;9(2):146-153. doi: 10.5114/ceh.2023.128768. Epub 2023 Jun 23. Clin Exp Hepatol. 2023. PMID: 37502435 Free PMC article.
-
Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis.World J Hepatol. 2023 Apr 27;15(4):525-537. doi: 10.4254/wjh.v15.i4.525. World J Hepatol. 2023. PMID: 37206649 Free PMC article. Review.
-
Dietary Bacillus subtilis supplementation alleviates alcohol-induced liver injury by maintaining intestinal integrity and gut microbiota homeostasis in mice.Exp Ther Med. 2021 Nov;22(5):1312. doi: 10.3892/etm.2021.10747. Epub 2021 Sep 16. Exp Ther Med. 2021. PMID: 34630666 Free PMC article.
-
Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis.Front Pharmacol. 2024 Jan 8;14:1274261. doi: 10.3389/fphar.2023.1274261. eCollection 2023. Front Pharmacol. 2024. PMID: 38259268 Free PMC article.
-
Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trials.Front Med (Lausanne). 2024 Mar 28;11:1379333. doi: 10.3389/fmed.2024.1379333. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38618195 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials